3.
Results of univariate analysis
| Characteristic | n | Survival rate (%) | P | ||
| 1 year | 2 years | 3 years | |||
| Gender | 0.028 | ||||
| Female | 47 | 68.1 | 44.0 | 31.1 | |
| Male | 57 | 75.4 | 66.0 | 53.2 | |
| Age, years | 0.041 | ||||
| ≤60 | 62 | 75.8 | 62.4 | 54.3 | |
| >60 | 42 | 66.7 | 46.7 | 27.6 | |
| Tumor number | 0.503 | ||||
| Solitary | 62 | 75.8 | 58.8 | 44.0 | |
| Multiple | 42 | 66.7 | 52.4 | 43.7 | |
| Tumor diameter, cm | 0.059 | ||||
| ≤5 | 50 | 76.0 | 60.9 | 53.7 | |
| >5 | 54 | 68.5 | 48.9 | 32.4 | |
| Hepatitis B | 0.896 | ||||
| Negative | 59 | 74.6 | 56.8 | 44.1 | |
| Positive | 45 | 68.9 | 52.4 | 43.0 | |
| Liver cirrhosis | 0.649 | ||||
| Negative | 67 | 71.6 | 56.2 | 44.7 | |
| Positive | 37 | 73.0 | 52.6 | 41.4 | |
| Fer | 0.010 | ||||
| Normal | 53 | 83.0 | 67.2 | 55.9 | |
| Higher | 51 | 60.8 | 42.0 | 31.5 | |
| CEA | 0.042 | ||||
| Normal | 83 | 75.9 | 60.6 | 46.5 | |
| Higher | 21 | 57.1 | 38.1 | 31.7 | |
| CA-199 | 0.038 | ||||
| Normal | 55 | 80.0 | 62.4 | 52.5 | |
| Higher | 49 | 63.3 | 46.2 | 34.6 | |
| AFP | 0.632 | ||||
| Normal | 81 | 70.4 | 54.8 | 43.7 | |
| Higher | 23 | 78.3 | 60.6 | 44.2 | |
| AJCC stage | 0.000 | ||||
| I/II | 68 | 82.4 | 71.1 | 54.0 | |
| III/IVa/IVb | 36 | 52.8 | 27.8 | 23.8 | |
| Differentiation | 0.009 | ||||
| Poor | 54 | 68.5 | 48.7 | 28.4 | |
| Well or moderate | 50 | 76.0 | 63.6 | 59.9 | |
| Vascular invasion | 0.689 | ||||
| Negative | 69 | 71.0 | 55.9 | 42.5 | |
| Positive | 35 | 74.3 | 56.1 | 46.8 | |
| LNM | 0.003 | ||||
| Negative | 93 | 76.3 | 59.5 | 47.8 | |
| Positive | 11 | 36.4 | 27.3 | 0 | |
| LND | 0.032 | ||||
| HLL | 21 | 47.6 | 28.6 | 28.6 | |
| EHLL | 12 | 75.0 | 66.7 | 33.3 | |
| NL | 71 | 78.9 | 62.5 | 47.8 | |